These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 709539)

  • 21. Serum copper investigations in children with acute lymphoblastic leukemia.
    Legutko L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(2):248-54. PubMed ID: 79530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
    Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM
    Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electron spin resonance as a useful technique in the management of Hodgkin's disease.
    Foster M; Fell L; Pocklington T; Akinsete F; Dawson A; Hutchison JM; Mallard JR
    Clin Radiol; 1977 Jan; 28(1):15-22. PubMed ID: 192508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic changes in red blood cells in malignant lymphomas.
    De Bellis R; Boulard MR; Kasdorf H; Rodriguez I; Ferrando R; Di Landro J; Ferrari M; Sanguinett CM; Tanzer J
    Br J Haematol; 1979 May; 42(1):35-9. PubMed ID: 465359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostics of relapse in hodgkin's disease (author's transl)].
    Dietzel F; Grebe SF; Ristig W; Schmidt HG; Steckenmesser R
    Med Klin; 1974 Feb; 69(7):289-92. PubMed ID: 4363084
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapeutic implications and sites of relapse predicted by elevated posttherapy erythrocyte sedimentation rate in early stage Hodgkin disease.
    Friedman S; Henry-Amar M; Cosset JM; Carde P; Hayat M; Dupouy N; Tubiana M
    Am J Hematol; 1991 Aug; 37(4):253-7. PubMed ID: 1858782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of age on treatment results in children and adolescents with Hodgkin's disease].
    Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M
    Przegl Lek; 2004; 61 Suppl 2():40-4. PubMed ID: 15686044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum copper level in non-Hodgkin's lymphomas.
    Salvagno L; Pappagallo GL; Chiarion Sileni V; Segati R; Cartei G; Endrizzi L; Paccagnella A; Ongaro G; Bonvicini P; Fiorentino MV
    Tumori; 1982 Feb; 68(1):57-62. PubMed ID: 7071946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group.
    Josting A; Franklin J; May M; Koch P; Beykirch MK; Heinz J; Rudolph C; Diehl V; Engert A
    J Clin Oncol; 2002 Jan; 20(1):221-30. PubMed ID: 11773173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant lymphoma: monitoring of tumour status in 273 patients using a monoclonal antibody, 'B5', reacting with autologous erythrocytes.
    Bruce L; Hancock BW; Cawood L
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):719-22. PubMed ID: 3653191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.
    Dann EJ; Daugherty CK; Larson RA
    Bone Marrow Transplant; 1997 Sep; 20(5):369-74. PubMed ID: 9339751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The erythrocyte sedimentation rate as a monitor for relapse in patients with previously treated Hodgkin's disease.
    Le Bourgeois JP; Tubiana M
    Int J Radiat Oncol Biol Phys; 1977; 2(3-4):241-7. PubMed ID: 863759
    [No Abstract]   [Full Text] [Related]  

  • 33. [Serum copper and zinc levels in patients with malignant neoplasm of the urogenital tract].
    Sanada S; Ogura K; Kiriyama T; Yoshida O
    Hinyokika Kiyo; 1985 Aug; 31(8):1299-316. PubMed ID: 4083194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total serum haemolytic complement activity, erythrocyte sedimentation rate and plasma fibrinogen as indicators of the stage in Hodgkin's disease.
    Wagener DJ; Haanen C
    Eur J Clin Invest; 1977 Aug; 7(4):289-94. PubMed ID: 408150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic importance of serum transferrin and ferritin in childhood Hodgkin's disease.
    Hann HW; Lange B; Stahlhut MW; McGlynn KA
    Cancer; 1990 Jul; 66(2):313-6. PubMed ID: 2369713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum copper levels in non-Hodgkin's lymphoma.
    Shah-Reddy I; Khilanani P; Bishop CR
    Cancer; 1980 Apr; 45(8):2156-9. PubMed ID: 6989485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleoli in lymphocytes of the peripheral blood in Hodgkin's disease: I. Changes in the course of the disease.
    Dientsbier Z; Foltýnová V; Rezný Z; Vĕtrovcová E
    Czech Med; 1978; 1(3):142-52. PubMed ID: 699718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the prognostic meaning of C-reactive protein (CRP) in children and adolescents with classical Hodgkin's lymphoma (HL).
    Haase R; Vilser C; Mauz-Körholz C; Hasenclever D; Kluge R; Ruschke K; Borkhardt A; Seeger K; Lehrnbecher T; Kulozik A; Rößler J; Burdach S; Jürgens H; Körholz D
    Klin Padiatr; 2012 Oct; 224(6):377-81. PubMed ID: 23047832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
    Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL
    Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The erythrocyte sedimentation rate. Still a helpful test when used judiciously.
    Brigden M
    Postgrad Med; 1998 May; 103(5):257-62, 272-4. PubMed ID: 9590999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.